Neuren Pharmaceuticals Limited (NEU.AX)
AUD 12.54
(-2.79%)
AUD 12.54
(-2.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 184.92 Million | 3.59 Million | -9.97 Million | -8.07 Million | -11.71 Million | 6.4 Million |
| Net Income | 157.08 Million | 184 Thousand | -7.79 Million | -9.19 Million | -10.81 Million | 3.07 Million |
| Depreciation & Amortization | 17 Thousand | 10 Thousand | 8000.00 | 6000.00 | 4000.00 | 77 Thousand |
| Deferred income taxes | -2.92 Million | -1.47 Million | -3.47 Million | -414.99 Thousand | - | - |
| Stock-based compensation | 2.92 Million | 1.98 Million | 840 Thousand | 394 Thousand | - | - |
| Change in working capital | 23.23 Million | 533 Thousand | -2.62 Million | -9000.00 | -1.02 Million | -250 Thousand |
| Other non-cash items | 4.59 Million | 2.35 Million | 3.07 Million | 1.13 Million | 117 Thousand | 3.5 Million |
| Investing Cash Flow | -211.48 Million | -19 Thousand | -10 Thousand | -6000.00 | -12 Thousand | - |
| Investments in PPE | -40 Thousand | -19 Thousand | -10 Thousand | -6000.00 | -12 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -211.44 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -211.44 Million | - | - | - | - | - |
| Financing Cash Flow | 3.61 Million | -2000.00 | 22.17 Million | 19.14 Million | 1.86 Million | 11.71 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -18 Thousand | -2000.00 | -1.1 Million | -1.07 Million | - | -16 Thousand |
| Common Stock Issuance | 3.61 Million | -2000.00 | 22.17 Million | 19.14 Million | 1.86 Million | 11.71 Million |
| Other Financing Activities | 18 Thousand | -2000.00 | 1.1 Million | 1.07 Million | 1.86 Million | 16 Thousand |
| Accounts receivables | -15.55 Million | 194 Thousand | -2.5 Million | -203 Thousand | 390 Thousand | -250 Thousand |
| Accounts payables | 2.44 Million | 339 Thousand | -114 Thousand | 194 Thousand | -1.41 Million | 393 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 36.34 Million | - | - | - | - | -393 Thousand |
| Cash at beginning of period | 40.18 Million | 36.78 Million | 24.18 Million | 13.84 Million | 23.57 Million | 4.7 Million |
| Cash at end of period | 17.09 Million | 40.18 Million | 36.78 Million | 24.18 Million | 13.84 Million | 23.57 Million |
| Capital Expenditure | -40 Thousand | -19 Thousand | -10 Thousand | -6000.00 | -12 Thousand | - |
| Effect of forex changes on cash | -145 Thousand | -181 Thousand | 400 Thousand | -713 Thousand | 139 Thousand | 748 Thousand |
| Net cash flow / Change in cash | -23.08 Million | 3.39 Million | 12.59 Million | 10.34 Million | -9.73 Million | 18.87 Million |
| Free Cash Flow | 184.88 Million | 3.58 Million | -9.98 Million | -8.08 Million | -11.73 Million | 6.4 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.01 Million | 157.08 Million | 109.27 Million | 47.8 Million | 184 Thousand | 7.23 Million |
| Depreciation & Amortization | 11 Thousand | 17 Thousand | 11 Thousand | 6000.00 | 10 Thousand | 6000.00 |
| Deferred income taxes | - | -2.92 Million | -1.91 Million | -1.04 Million | -1.47 Million | -850 Thousand |
| Stock-based compensation | 765 Thousand | 2.92 Million | 1.89 Million | 1.03 Million | 1.98 Million | 838 Thousand |
| Change in working capital | 3.74 Million | 23.23 Million | 26.82 Million | -3.58 Million | 533 Thousand | 300 Thousand |
| Other non-cash items | -33.07 Million | 4.59 Million | 3.95 Million | 666 Thousand | 2.35 Million | 1.88 Million |
| Investing Cash Flow | 840 Thousand | -211.48 Million | -211.46 Million | -18 Thousand | -19 Thousand | -9000.00 |
| Investments in PPE | -3000.00 | -40 Thousand | -22 Thousand | -18 Thousand | -19 Thousand | -9000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -211.44 Million | -211.44 Million | - | - | - |
| Sales/Maturities of investments | 843 Thousand | - | - | - | - | - |
| Other Investing Activities | 843 Thousand | -211.44 Million | -211.44 Million | - | - | - |
| Financing Cash Flow | 1.65 Million | 3.61 Million | 2.52 Million | 1.09 Million | -2000.00 | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -18 Thousand | - | - | -2000.00 | - |
| Common Stock Issuance | 1.65 Million | 3.61 Million | 2.52 Million | 1.09 Million | -2000.00 | - |
| Other Financing Activities | 1.65 Million | 18 Thousand | 2.52 Million | 1.09 Million | -2000.00 | - |
| Accounts receivables | 3.74 Million | -15.55 Million | -15.55 Million | - | 194 Thousand | 194 Thousand |
| Accounts payables | 1.05 Million | 2.44 Million | - | - | 339 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -32.23 Million | 36.34 Million | 3.58 Million | -3.58 Million | - | -233 Thousand |
| Cash at beginning of period | 17.09 Million | 40.18 Million | 38.38 Million | 40.18 Million | 36.78 Million | 31.08 Million |
| Cash at end of period | 2.57 Million | 17.09 Million | 17.09 Million | 38.38 Million | 40.18 Million | 40.18 Million |
| Capital Expenditure | -3000.00 | -40 Thousand | -22 Thousand | -18 Thousand | -19 Thousand | -9000.00 |
| Effect of forex changes on cash | 3.52 Million | -145 Thousand | 317 Thousand | -462 Thousand | -181 Thousand | -314 Thousand |
| Net cash flow / Change in cash | -14.52 Million | -23.08 Million | -21.29 Million | -1.79 Million | 3.39 Million | 9.09 Million |
| Free Cash Flow | -20.53 Million | 184.88 Million | 140.02 Million | 44.86 Million | 3.58 Million | 9.4 Million |
3712
KDKCF
0I4Q
EEFT
KUWERIN
4238